Rosenberg Matthew Hamilton Merck & Co., Inc. Transaction History

Rosenberg Matthew Hamilton

$458 Million
Q3 2025

A detailed history of Rosenberg Matthew Hamilton transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 4,993 shares of MRK stock, worth $463,649. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,993

Previous 5,033 0.79%

Holding current value

$463,649

Previous $398,000 5.28%

% of portfolio

0.09%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$77.6 - $87.37 $3,104 - $3,494	-40 Reduced 0.79%	4,993 $419,000
Q2 2025 Jul 28, 2025	BUY	$73.47 - $87.12 $99,111 - $117,524	1,349 Added 36.62%	5,033 $398,000
Q1 2025 Apr 28, 2025	BUY	$83.01 - $101.02 $38,931 - $47,378	469 Added 14.59%	3,684 $330,000
Q4 2024 Jan 13, 2025	SELL	$96.31 - $114.76 $36,116 - $43,035	-375 Reduced 10.45%	3,215 $319,000
Q3 2024 Oct 28, 2024	BUY	$111.15 - $128.97 $17,895 - $20,764	161 Added 4.7%	3,590 $407,000

Q2 2024 Jul 26, 2024	BUY	$123.8 - $132.96 $41,844 - $44,940	338 Added 10.93%	3,429 $424,000
Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $28,762 - $33,515	-254 Reduced 7.59%	3,091 $407,000
Q4 2023 Jan 12, 2024	BUY	$100.18 - $109.02 $5,910 - $6,432	59 Added 1.8%	3,345 $364,000
Q3 2023 Oct 11, 2023	SELL	$102.95 - $114.33 $38,915 - $43,216	-378 Reduced 10.32%	3,286 $338,000
Q2 2023 Jul 26, 2023	SELL	$108.61 - $118.38 $48,440 - $52,797	-446 Reduced 10.85%	3,664 $422,000
Q1 2023 Apr 17, 2023	BUY	$102.94 - $114.86 $102 - $114	1 Added 0.02%	4,110 $437,000
Q4 2022 Jan 18, 2023	BUY	$87.44 - $112.11 $6,470 - $8,296	74 Added 1.83%	4,109 $0
Q3 2022 Oct 21, 2022	BUY	$84.53 - $94.96 $35,840 - $40,263	424 Added 11.74%	4,035 $347,000
Q2 2022 Jul 15, 2022	BUY	$83.49 - $94.64 $27,384 - $31,041	328 Added 9.99%	3,611 $334,000
Q1 2022 Apr 14, 2022	BUY	$73.51 - $82.4 $50,133 - $56,196	682 Added 26.22%	3,283 $269,000
Q4 2021 Jan 20, 2022	SELL	$72.28 - $90.54 $16,190 - $20,280	-224 Reduced 7.93%	2,601 $199,000
Q3 2021 Oct 12, 2021	BUY	$71.68 - $78.83 $50,964 - $56,048	711 Added 33.63%	2,825 $212,000
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $3,515 - $3,888	50 Added 2.42%	2,114 $164,000
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $7,712 - $9,084	112 Added 5.74%	2,064 $159,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $27,990 - $31,063	390 Added 24.97%	1,952 $160,000
Q3 2020 Oct 16, 2020	BUY	$73.18 - $82.95 $9,293 - $10,534	127 Added 8.85%	1,562 $130,000
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $8,027 - $9,134	114 Added 8.63%	1,435 $111,000
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $83,698 - $116,010	1,321 New	1,321 $102,000

Others Institutions Holding MRK

# of Institutions

3,878

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.

Account

Rosenberg Matthew Hamilton Merck & Co., Inc. Transaction History